Abstract |
Spontaneous autoimmune peripheral polyneuropathy (SAPP) is a mouse model of chronic inflammatory demyelinating polyradiculoneuropathy ( CIDP) in non-obese diabetic (NOD) mice null for costimulatory molecule, B7-2 gene (B7-2-/-). SAPP is a chronic progressive and multifocal inflammatory and demyelinating polyneuropathy of spontaneous onset with secondary axonal degeneration. Insulin-like growth factor 1(IGF-1) is a pleiotropic factor with neuroprotective, regenerative, and anti-inflammatory effects with extensive experience in its preclinical and clinical use. Systemic delivery of recombinant adeno-associated virus serotype 9 (rAAV9) provides robust and widespread gene transfer to central and peripheral nervous systems making it suitable for gene delivery in neurological diseases. A significant proportion of patients with inflammatory neuropathies like CIDP do not respond to current clinical therapies and there is a need for new treatments. In this study, we examined the efficacy IGF-1 gene therapy by systemic delivery with rAAV9 in SAPP model. The rAAV9 construct also contained a reporter gene to monitor the surrogate expression of IGF-1. We found significant improvement in neuropathic disease after systemic delivery of rAAV9/IGF-1 gene at presymptomatic and symptomatic stages of SAPP model. These findings support that IGF-1 treatment (including gene therapy) is a viable therapeutic option in immune neuropathies such as CIDP.
|
Authors | Tong Gao, Nataliia Bogdanova, Sameera Ghauri, Gang Zhang, Jianxin Lin, Kazim Sheikh |
Journal | Scientific reports
(Sci Rep)
Vol. 8
Issue 1
Pg. 5408
(04 03 2018)
ISSN: 2045-2322 [Electronic] England |
PMID | 29615658
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA, Recombinant
- Insulin-Like Growth Factor I
|
Topics |
- Animals
- Asymptomatic Diseases
- DNA, Recombinant
(genetics)
- Dependovirus
(genetics)
- Disease Models, Animal
- Gene Transfer Techniques
- Genetic Therapy
- Insulin-Like Growth Factor I
(genetics)
- Mice
- Peripheral Nerve Injuries
(complications)
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
(complications, genetics, therapy)
|